Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial
Authors:
Open Access
- 20 October 2020
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (4) , 48
Abstract
The prevalence of obesity is increasing worldwide and is commonly associated with comorbidities. The use of several drugs is often necessary, which leads to Potential Drug Interactions (PDI) that may increase the morbidity and mortality. This study aimed to analyze the prevalence of drug interaction and its association with socio-demographics, health status, and drug use in severely obese individuals. Baseline data from a randomized clinical trial registered at Clinicaltrial.gov (NCT02463435) were used. A total of 150 individuals aged 18–65 years with a body mass index of 35 kg/m2 were included. The outcome variable was the presence of PDI, and the explanatory variables were divided into the following four levels: socio-demographic, lifestyle, health, and medication use. The prevalence of PDI was 50% (n = 75) (95% CI 41–58). The variables associated with drug–drug interactions in the multiple analyses were arterial hypertension (PR 1.83, 95%, CI 1.10–3.04), polypharmacy (PR 3.12, 95%, CI 2.17–4.50), and diabetes mellitus (PR 0.60, 95%, CI 0.45–0.81). The risk factors for the occurrence of drug interaction were the presence of diabetes mellitus, hypertension, and polypharmacy.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Goiás (201310267000003)
This publication has 43 references indexed in Scilit:
- Obesity Is Associated with an Increase in Pharmaceutical Expenses among University EmployeesJournal of Obesity, 2015
- Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical careJournal of Clinical Pharmacy and Therapeutics, 2014
- A systematic review of qualitative research on the contributory factors leading to medicine-related problems from the perspectives of adult patients with cardiovascular diseases and diabetes mellitusBMJ Open, 2014
- O Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas Não Transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisãoEpidemiologia e Serviços de Saúde, 2013
- Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort StudyPLOS ONE, 2012
- ACCF/AHA/AMA–PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and HypertensionCirculation, 2011
- The epidemiology of medication errors: the methodological difficultiesBritish Journal of Clinical Pharmacology, 2009
- Hepatic Histopathology of Morbid Obesity: Concurrence of Other Forms of Chronic Liver DiseaseObesity Surgery, 2006
- Putative contributors to the secular increase in obesity: exploring the roads less traveledInternational Journal of Obesity, 2006
- Pharmaceutical Costs in Obese IndividualsArchives of internal medicine (1960), 2002